Vinva Investment Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.97M Sell
14,988
-4,303
-22% -$892K 0.02% 274
2026
Q1
$4.24M Buy
19,291
+3,820
+25% +$952K 0.05% 227
2025
Q4
$3.76M Buy
15,471
+8,421
+119% +$2.15M 0.05% 224
2025
Q3
$1.91M Sell
7,050
-2,031
-22% -$555K 0.04% 262
2025
Q2
$2.32M Sell
9,081
-981
-10% -$234K 0.06% 232
2025
Q1
$2.21M Buy
10,062
+1,447
+17% +$338K 0.09% 215
2024
Q4
$1.98M Sell
8,615
-12,288
-59% -$2.96M 0.08% 225
2024
Q3
$5M Buy
20,903
+14,820
+244% +$3.31M 0.21% 116
2024
Q2
$1.17M Buy
6,083
+1,268
+26% +$257K 0.06% 273
2024
Q1
$954K Buy
+4,815
New +$882K 0.05% 295

Other funds holding RMD

Vinva Investment Management's RMD Position: Q2 2026 in Review

Vinva Investment Management reduced its ResMed (RMD) stake by 22% in Q2 2026, selling an estimated $892K and leaving 14,988 shares worth $2.97M. The position accounts for 0.02% of the portfolio, ranked #274.

Vinva Investment Management first reported a position in RMD in Q1 2024 and has held it in 10 quarters since. The position peaked at $5M in Q3 2024. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Vinva Investment Management held 14,988 shares of ResMed worth $2.97M as of Q2 2026.
  • Vinva Investment Management sold 4,303 ResMed shares in Q2 2026, an estimated $892K.
  • ResMed made up 0.02% of Vinva Investment Management's portfolio in Q2 2026, its #274 holding.
  • Vinva Investment Management first reported a position in ResMed in Q1 2024 and has held it in 10 quarters since.
  • Vinva Investment Management's ResMed position peaked at $5M in Q3 2024.
  • 891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Vinva Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.